Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.047; wR factor = 0.123; data-to-parameter ratio = 11.7.
Related literature
For background to the biological activity, pharmacokinetic properties and therapeutic use of pefloxacin, a synthetic chemotherapeutic agent used to treat severe bacterial infections, see: Mizuki et al. (1996) ; Gonzalez & Henwood (1989) ; Tripathi (1995) ; Ross & Riley (1990) ; Burkhardt et al. (1997) . For the silver(I), manganese(II) and cobalt(II) derivatives of the pefloxacin anion, see : Baenziger et al. (1986) ; An, Huang & Qi (2007) ; An, Qi & Huang (2007) . For related structures, see; An & Liang (2008) ; Florence et al. (2000) ; Hu & Yu (2005) ; Parvez et al. (2000) . For hydrogen-bonding motifs see: Bernstein et al. (1995) . For ring conformations, see : Cremer & Pople (1975) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
D-HÁ
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 
Comment
Pefloxacin is a synthetic chemotherapeutic agent used to treat severe and life-threatening bacterial infections (Mizuki et al., 1996) . A review of its anti-bacterial activity, pharmacokinetic properties and therapeutic use is available (Gonzalez & Henwood, 1989) . Pefloxacin is commonly referred to as a fluoroquinolone (or quinolone) drug and is a member of the fluoroquinolone class of anti-bacterials. It is an analog of norfloxacin and is a synthetic fluoroquinolone, belonging to the third generation of quinolones. As an antibacterial drug, it is highly effective against both Gram-negative and Gram-positive pathogens that are resistant to other anti-bacterials (Tripathi, 1995; Ross et al., 1990) . Pefloxacin is well known to be associated with high incidence of arthropathy in humans because the drug affects articular cartilage and the epiphyseal growth plate (Burkhardt et al., 1997) . The silver(I), manganese(II) and cobalt(II) derivatives of the pefloxacin anion have been reported (Baenziger et al., 1986; An, Huang, & Qi, 2007; An, Qi & Huang, 2007) . The crystal structures of silver pefloxacin (Baenziger et al., 1986) , pefloxacinium methane sulfonate 0.10-hydrate (Parvez et al., 2000) , norfloxacin dihydrate (Florence et al., 2000) , norfloxacin picrate (Hu & Yu, 2005) , 1-ethyl-6-fluoro-7-(4-methylpiperazin-4-ium-1-yl) -4-oxo-1,4-dihydroquinoline-3-carboxylate hexahydrate (An & Liang, 2008) have been reported. In view of the importance of pefloxacin, this paper reports the crystal structure of the title compound.
The asymmetric unit of the title compound ( Fig. 1) , contains a protonated pefloxacinium cation and a picrate anion. The cation is composed of an essentially planar quinoline ring system [maximum deviation 0.021 (2) Å]. The six-membered piperazinyl ring adopts a chair conformation with puckering parameters (Cremer & Pople, 1975 In the crystal structure (Fig. 2) , the picrate anion interacts with the cations through bifurcated N6-H1N6···O1 and N6-H1N6···O7 hydrogen bonds, forming an R 1 2 (6) (Bernstein et al., 1995) ring motif. There is an intramolecular O9-H1O9···O10 hydrogen bond between the carbonyl and carboxyl groups in the cation, which generates an S(6) ring motif. The crystal structure is further stabilized by several weak C-H···O and C-H···F interactions (Table 1) , forming a three-dimensional network. Also, π-π interactions between pyridine rings, and between benzene rings of anions/anions, with centroid-to-centroid distances = 3.6103 (12) Å and 3.5298 (11) Å, respectively, are observed.
Experimental
Each of the pefloxacin (3.33 g, 0.01 mol) and picric acid (2.29 g, 0.01 mol) were individually dissolved in water (60 ml).
The solutions were mixed and 5 M HCl (2 ml) was added with stirring for a few minutes. The product formed was filtered and dried. Yellow crystals of pefloxacinium picrate were obtained by slow evaporation in DMF (m.p.: 515 K). Figures Fig. 1 . The asymmetric unit of the title compound, showing 50% probability displacement ellipsoids and the atom-numbering scheme. 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. sup-6 
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